IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Orbimed Advisors LLC

Q1 2025 Holdings

Filed 2025-05-15 | 111 holdings | $4.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Unitedhealth Group Inc(UNH)COM91324P102$105.4M201,2002.5%
Edwards Lifesciences Corp(EW)COM28176E108$111.0M1,532,0002.6%
Argenx SE(ARGX)SPONSORED ADR04016X101$122.3M206,7002.9%
Stryker Corporation(SYK)COM863667101$133.7M359,2003.2%
Intuitive Surgical Inc(ISRG)COM NEW46120E602$144.1M291,0003.4%
Enliven Therapeutics Inc(ELVN)COM29337E102$156.6M7,959,5383.7%
ELI Lilly & Co(LLY)COM532457108$278.8M337,6006.6%
Boston Scientific Corp(BSX)COM101137107$283.8M2,813,2006.8%
Edgewise Therapeutics Inc(EWTX)COM28036F105$330.5M15,021,7217.9%
Sinovac Biotech LTD(SVA)SHSP8696W104$334.0M2,718,7358.0%
PreviousPage 3 of 3